Huayue Li1, John J Bowling2, Mingzhi Su3, Jongki Hong4, Bong-Jin Lee5, Mark T Hamann6, Jee H Jung7. 1. College of Pharmacy, Pusan National University, Busan 609-735, Republic of Korea. Electronic address: lihuayue@naver.com. 2. Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, Oxford, MN 38677, USA. Electronic address: bowlingjj@gmail.com. 3. College of Pharmacy, Pusan National University, Busan 609-735, Republic of Korea. Electronic address: smz0310@163.com. 4. College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea. Electronic address: jhong@khu.ac.kr. 5. College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea. Electronic address: lbj@nmr.snu.ac.kr. 6. Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, Oxford, MN 38677, USA. Electronic address: mthamann@olemiss.edu. 7. College of Pharmacy, Pusan National University, Busan 609-735, Republic of Korea. Electronic address: jhjung@pusan.ac.kr.
Abstract
BACKGROUND: Known linear knottins are unsuitable as scaffolds for oral peptide drug due to their gastrointestinal instability. Herein, a new subclass of knottin peptides from Porifera is structurally described and characterized regarding their potential for oral peptide drug development. METHODS: Asteropsins B-D (ASPB, ASPC, and ASPD) were isolated from the marine sponge Asteropus sp. The tertiary structures of ASPB and ASPC were determined by solution NMR spectroscopy and that of ASPD by homology modeling. RESULTS: The isolated asteropsins B-D, together with the previously reported asteropsin A (ASPA), compose a new subclass of knottins that share a highly conserved structural framework and remarkable stability against the enzymes in gastrointestinal tract (chymotrypsin, elastase, pepsin, and trypsin) and human plasma. CONCLUSION: Asteropsins can be considered as promising peptide scaffolds for oral bioavailability. GENERAL SIGNIFICANCE: The structural details of asteropsins provide essential information for the engineering of orally bioavailable peptides.
BACKGROUND: Known linear knottins are unsuitable as scaffolds for oral peptide drug due to their gastrointestinal instability. Herein, a new subclass of knottin peptides from Porifera is structurally described and characterized regarding their potential for oral peptide drug development. METHODS:Asteropsins B-D (ASPB, ASPC, and ASPD) were isolated from the marine sponge Asteropus sp. The tertiary structures of ASPB and ASPC were determined by solution NMR spectroscopy and that of ASPD by homology modeling. RESULTS: The isolated asteropsins B-D, together with the previously reported asteropsin A (ASPA), compose a new subclass of knottins that share a highly conserved structural framework and remarkable stability against the enzymes in gastrointestinal tract (chymotrypsin, elastase, pepsin, and trypsin) and human plasma. CONCLUSION:Asteropsins can be considered as promising peptide scaffolds for oral bioavailability. GENERAL SIGNIFICANCE: The structural details of asteropsins provide essential information for the engineering of orally bioavailable peptides.
Authors: Ralph Krätzner; Judit E Debreczeni; Thomas Pape; Thomas R Schneider; Alexander Wentzel; Harald Kolmar; George M Sheldrick; Isabel Uson Journal: Acta Crystallogr D Biol Crystallogr Date: 2005-08-16
Authors: Martin Werle; Thierry Schmitz; Hong-Lei Huang; Alexander Wentzel; Harald Kolmar; Andreas Bernkop-Schnürch Journal: J Drug Target Date: 2006-04 Impact factor: 5.121
Authors: Lauren R H Krumpe; Brice A P Wilson; Christophe Marchand; Suthananda N Sunassee; Alun Bermingham; Wenjie Wang; Edmund Price; Tad Guszczynski; James A Kelley; Kirk R Gustafson; Yves Pommier; K Johan Rosengren; Christina I Schroeder; Barry R O'Keefe Journal: J Am Chem Soc Date: 2020-12-02 Impact factor: 15.419